|
|
 |
ACACIA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
GOPRELTO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
HYDROCHLORIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INDIGOTINDISULFONATE SODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INBRIJA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|